<DOC>
	<DOC>NCT02897661</DOC>
	<brief_summary>Patients with Crohns' disease are always complicated with malnutrition. This trial aimed to assess whether FMT accompanied by enteral nutrition (EN) can make contributions to patients with Crohns' disease.</brief_summary>
	<brief_title>Fecal Microbiota Transplantation Improves Nutritional State of Patients With Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>1. patients aged from 18 to 65, regardless of gender; 2. moderate to severe active CD patients(CDAI＞220)，accompanied with malnutrition; 3. infection status; 4. patients with high compliance; 5. suitable for fecal microbiota transplantation and enteral nutrition therapy; 6. history of safe mesalazine use. 1. severe infection which affected vital signs; 2. parenteral infection such as urinary tract, lung and so on; 3. mycobacterium tuberculosis infection; 4. immunosuppressor or biologicals use within 6 week; 5. allergic to metronidazole,salicylic acid preparation, etc; 6. complicated with perianal Crohn's disease, intestinal fistula, intestinal obstruction; 7. accompanied by any severe disease such as cancer or AIDS; 8. patients who are in pregnant or going to pregnant; 9. patients who has disability mentally and physically.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>fecal microbiota transplantation</keyword>
	<keyword>enteral nutrition</keyword>
</DOC>